Literature DB >> 24634571

Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.

Rhiannon M Kelsh1, Paula J McKeown-Longo1.   

Abstract

The relationship between cancer progression and chronic inflammation is well documented but poorly understood. The innate immune system has long been recognized as the first line of defense against invading pathogens. More recently, endogenous molecules released from tissue matrix (Damage Associated Molecular Patterns [DAMPs]) following tissue injury or periods of active matrix remodeling have also been identified as regulators of innate immunity. DAMPs have been identified as ligands for Toll-like receptors (TLRs), a family of cell-surface proteins which regulate the immune response. TLRs have been identified on resident tissue cells as well as most tumor cells. Therefore, dysregulation of the innate immune response secondary to biochemical and mechanical driven changes in the extracellular matrix of the tumor microenvironment may be a critical component of the chronic inflammation associated with tumor progression. Here we review the role of extracellular matrix (ECM)-derived DAMPS in the activation of TLR4 signaling in the context of tumor progression. We also explore the various types of topographical changes that can lead to ECM-derived DAMPs and their contribution to TLR4 activation.

Entities:  

Keywords:  DAMP; extracellular matrix; fibronectin; toll-like receptor-4

Year:  2013        PMID: 24634571      PMCID: PMC3952558     

Source DB:  PubMed          Journal:  Trends Cancer Res        ISSN: 0973-1040


  120 in total

1.  Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

Authors:  Geoffrey B Johnson; Gregory J Brunn; Yuzo Kodaira; Jeffrey L Platt
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

Review 2.  An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion.

Authors:  François-Xavier Maquart; Sylvie Pasco; Laurent Ramont; William Hornebeck; Jean-Claude Monboisse
Journal:  Crit Rev Oncol Hematol       Date:  2004-03       Impact factor: 6.312

3.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 4.  The paradox of pro-inflammatory cytokines in cancer.

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

5.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

Authors:  Beatrice E Bachmeier; Isabelle V Mohrenz; Valentina Mirisola; Erwin Schleicher; Francesco Romeo; Clara Höhneke; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

7.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.

Authors:  G Westergren-Thorsson; J Hernnäs; B Särnstrand; A Oldberg; D Heinegård; A Malmström
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Inflammation-associated lysyl oxidase protein expression in vivo, and modulation by FGF-2 plus IGF-1.

Authors:  P C Trackman; R J Graham; H K Bittner; D L Carnes; J A Gilles; D T Graves
Journal:  Histochem Cell Biol       Date:  1998-07       Impact factor: 4.304

9.  Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.

Authors:  Verena Voelcker; Carl Gebhardt; Marco Averbeck; Anja Saalbach; Verena Wolf; Falk Weih; Jonathan Sleeman; Ulf Anderegg; Jan Simon
Journal:  Exp Dermatol       Date:  2007-11-21       Impact factor: 3.960

10.  Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site.

Authors:  Bin Li; Alicia Vincent; Justin Cates; Dana M Brantley-Sieders; D Brent Polk; Pampee P Young
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

View more
  17 in total

1.  Transcriptional Profiling of the Chicken Tracheal Response to Virulent Mycoplasma gallisepticum Strain Rlow.

Authors:  J Beaudet; E R Tulman; K Pflaum; X Liao; G F Kutish; S M Szczepanek; L K Silbart; S J Geary
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

2.  The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts.

Authors:  Arti V Shinde; Rhiannon Kelsh; John H Peters; Kiyotoshi Sekiguchi; Livingston Van De Water; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2014-11-26       Impact factor: 11.583

Review 3.  Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program.

Authors:  Paula J McKeown-Longo; Paul J Higgins
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

Review 4.  Toll-like receptor-4 modulation for cancer immunotherapy.

Authors:  Shanjana Awasthi
Journal:  Front Immunol       Date:  2014-07-25       Impact factor: 7.561

5.  The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.

Authors:  Christina Cho; Carol Horzempa; David Jones; Paula J McKeown-Longo
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

6.  Viperid Envenomation Wound Exudate Contributes to Increased Vascular Permeability via a DAMPs/TLR-4 Mediated Pathway.

Authors:  Alexandra Rucavado; Carolina A Nicolau; Teresa Escalante; Junho Kim; Cristina Herrera; José María Gutiérrez; Jay W Fox
Journal:  Toxins (Basel)       Date:  2016-11-24       Impact factor: 4.546

Review 7.  Innate Immunity and Biomaterials at the Nexus: Friends or Foes.

Authors:  Susan N Christo; Kerrilyn R Diener; Akash Bachhuka; Krasimir Vasilev; John D Hayball
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

8.  Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains.

Authors:  Rhiannon Kelsh; Ran You; Carol Horzempa; Mingzhe Zheng; Paula J McKeown-Longo
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

9.  Toll-Like Receptor 4 Reduces Oxidative Injury via Glutathione Activity in Sheep.

Authors:  Shoulong Deng; Kun Yu; Qian Wu; Yan Li; Xiaosheng Zhang; Baolu Zhang; Guoshi Liu; Yixun Liu; Zhengxing Lian
Journal:  Oxid Med Cell Longev       Date:  2015-11-10       Impact factor: 6.543

10.  Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer.

Authors:  Feng Wei; Fan Yang; Jing Li; Yu Zheng; Wenwen Yu; Lili Yang; Xiubao Ren
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.